Letters to the Editor

Copy number alterations define outcome in Philadelphia chromosome-positive acute lymphoblastic leukemia

Hematology Research Unit Helsinki, Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Department of Pathology, Zealand University Hospital, Roskilde
Hematology Research Unit Helsinki, Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; Laboratory of Genetics, HUS Diagnostic Center, Hospital District of Helsinki and Uusimaa (HUS), Helsinki, Finland; Medical and Clinical Genetics, University of Helsinki, Helsinki University Hospital, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki
Institute for Molecular Medicine Finland, University of Helsinki, Helsinki
Hematology Research Unit Helsinki, Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Division of Hematology, Oulu University Hospital, Oulu
Division of Hematology, Oulu University Hospital, Oulu
Division of Hematology, Tampere University Hospital, Tampere
Division of Hematology, Kuopio University Hospital, Kuopio
Division of Hematology, Turku University Hospital, Turku
Division of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Division of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Hematology Research Unit Helsinki, Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland; Department of Clinical Chemistry, University of Helsinki, Helsinki
Hematology Research Unit Helsinki, Translational Immunology Research Program, University of Helsinki and Helsinki University Hospital Comprehensive Cancer Center, Helsinki, Finland; iCAN Digital Precision Cancer Medicine Flagship, Helsinki, Finland; Division of Hematology, Helsinki University Hospital Comprehensive Cancer Center, Helsinki
Haematologica Early view Apr 28, 2022 https://doi.org/10.3324/haematol.2021.280578